Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Litfulo is recommended for treating severe alopecia areata in people 12 and older, as it helps hair regrowth.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Baricitinib successfully treated severe hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib is effective and safe for treating severe alopecia areata.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.